VIDEO: Daily Digit: Novo Nordisk shares slide

By  | 

Shares in Danish drugmaker Novo Nordisk fell by as much as 15%, after it was hit hard by U.S. regulators’ demands for further clinical testing of its new long-acting insulin drug Tresiba. Joanna Partridge reports

Thanks for checking us out. Please take a look at the rest of our videos and articles.

To stay in the loop, bookmark our homepage.